[Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000008:administration & dosage*; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017373:Cyproterone Acetate; D013196:Dihydrotestosterone / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006628:Hirsutism / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage*; D013739:Testosterone / Q000097:blood; D013997:Time Factors
D000726:Androgen Antagonists; D013196:Dihydrotestosterone; D013148:Spironolactone; D013739:Testosterone; D017373:Cyproterone Acetate; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003534:Cyproterone
Ciproterone acetato e spironolattone a confronto nella terapia dell'irsutismo femminile.